Checkmate Pharma Stock More Than Triples on $250M Acquisition by Regeneron
(Checkmate Pharma) Shares of Checkmate Pharmaceuticals soared more than 332% on Tuesday after agreeing to a $250 million cash deal by Regeneron. The deal values Checkmate stock at $10.50 per…